CodeSystem Comparison between http://terminology.hl7.org/CodeSystem/v2-0247 vs http://terminology.hl7.org/CodeSystem/v2-0247

Messages

ErrorCodeSystem.versionValues for version differ: '2.1.0' vs '2.0.0'
InformationCodeSystem.publisherValues for publisher differ: 'HL7, Inc' vs 'Health Level Seven International'
InformationCodeSystem.copyrightValues for copyright differ: 'Copyright HL7. Licensed under creative commons public domain' vs 'This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license'

Metadata

NameValueComments
.caseSensitivetrue
    .compositionalfalse
      .contentcomplete
        .copyrightCopyright HL7. Licensed under creative commons public domainThis material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license
        • Values Differ
        .date2019-12-01
          .descriptionHL7-defined code system of concepts that describes the status of product evaluation. Used in HL7 Version 2.x messaging in the PCR segment.
            .experimentalfalse
              .hierarchyMeaningis-a
                .jurisdiction
                  .nameStatusOfEvaluation
                    .publisherHL7, IncHealth Level Seven International
                    • Values Differ
                    .purposeUnderlying Master Code System for V2 table 0247 (Status of Evaluation)
                      .statusactive
                        .titlestatusOfEvaluation
                          .urlhttp://terminology.hl7.org/CodeSystem/v2-0247
                            .version2.1.02.0.0
                            • Values Differ
                            .versionNeededfalse

                              Concepts

                              CodeDisplaystatusdeprecatedstatusdeprecatedComments
                              .YEvaluation completedAAAA
                                .PEvaluation in progressAAAA
                                  .KProblem already known, no evaluation necessaryAAAA
                                    .XProduct not made by companyAAAA
                                      .AEvaluation anticipated, but not yet begunAAAA
                                        .DProduct discarded -- unable to follow upAAAA
                                          .CProduct received in condition which made analysis impossibleAAAA
                                            .IProduct remains implanted -- unable to follow upAAAA
                                              .UProduct unavailable for follow up investigationAAAA
                                                .QProduct under quarantine -- unable to follow upAAAA
                                                  .RProduct under recall/corrective actionAAAA
                                                    .OOtherAAAA